Drug Type Bispecific antibody |
Synonyms |
Target |
Action inhibitors |
Mechanism PAD2 inhibitors(peptidyl arginine deiminase 2 inhibitors), PAD4 inhibitors(peptidyl arginine deiminase 4 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Rheumatoid Arthritis | Phase 1 | United States | - |